 |
- Home
- Clinical Perspectives
- Business Perspectives
- Patient Care
- Learning
- Community
- Products
- Careers
- About Us
Post-vasectomy home sperm test receives FDA nod The FDA has approved SpermCheck Vasectomy (ContraVac, Inc., Charlottesville, VA), a diagnostic product that confirms men’s post-vasectomy sterility. The device will enable men to test their post-vasectomy fertility status at home, rather than returning to the physician’s office or a laboratory for confirmation. Similar to a home pregnancy test for women, the test has the sensitivity and specificity required to detect low numbers of sperm, according to ContraVac. The test will be available in mid-2008. Physicians will be able to provide the product to their patients who undergo vasectomy, or men can order the product directly from the vendor.  designed to meet the evolving needs of physicians, nurses and other allied healthcare professionals. |  Stay Connected to Urology Times • Current Issue • Issue Archive • Subscribe to Print Edition • Subscribe to Digital Edition • Urology Times Radio • Events Calendar  Practice Tools Coding Counselor Simple and accurate ICD-9 code search. Start Here  Formulary Counselor Find health plan drug coverage in your area. Start Here  Patient Education Print customized patient education handouts. Start Here  Surgical Video Center On-demand surgery demos and presentations. Start Here     Featured Jobs |
